Gut Microbiome Alterations in Alzheimer’s Disease: A Shotgun Metagenomic Case–Control Study
International Journal of Molecular Sciences · 25.10.2026 · 27 (21) · 9543
DOI: 10.3390/ijms27219543 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.10.2026. Verfasst von Argul Issilbayeva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Center ArtScience, Astana Z11F5A9, Kazakhstan. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome, Metagenomics. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Republic of Kazakhstan, Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.
Themen: Demenz
Abstract (Originalsprache)
The gut microbiome has been proposed as a contributor to Alzheimer’s disease (AD) pathogenesis via the microbiota–gut–brain axis, but findings across cohorts are inconsistent and scarce data exist from Central Asian populations. We used shotgun metagenomic sequencing to compare the gut microbiome of AD patients and cognitively healthy controls from Kazakhstan. In a cross-sectional case–control study (35 AD, 39 Control), we profiled taxonomic and functional (HUMAnN pathway) composition, and compared alpha/beta diversity, individual taxa and pathways, and their association with clinical and demographic variables (Mann–Whitney U test, PERMANOVA/PERMDISP, OLS regression, all BH-FDR corrected, sensitivity analysis using ANCOM-BC2), with sensitivity analyses adjusting for age and BMI and applying Bonferroni correction. Within the AD group, circulating adiponectin—measured only in this group—was examined for associations with microbiome features in an exploratory analysis. Alpha diversity was lower in AD (q < 0.05). Community composition also separated by group on PERMANOVA (R2 = 8.6%, p = 0.001), and this separation held after adjusting for age and BMI. A total of 178 taxa differed significantly between groups (BH-FDR; 37 were also Bonferroni-significant), most prominently depletion of Faecalibacterium and enrichment of Eisenbergiella and Desulfovibrio in AD; 100 pathways differed significantly (20 Bonferroni-significant). Three clinical/demographic variables (total bilirubin, atherogenic index, BMI) were associated with specific taxa or pathways. Within the AD group, adiponectin correlated negatively with the pathway assimilatory sulfate reduction IV (rho = −0.60, q = 0.015). AD in this Central Asian cohort was associated with a less diverse, compositionally distinct gut microbiome, with depletion of butyrate-producing Firmicutes and enrichment of sulfate-reducing taxa, alongside other taxa whose direction of association differed from prior reports.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Innovative Center ArtScience, Astana Z11F5A9, Kazakhstan.
- Laboratory of Microbiome, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana Z05H0P9, Kazakhstan.
- Laboratory of Bioengineering and Regenerative Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana Z05H0P9, Kazakhstan.
- Laboratory of Food Biotechnology and Specialty Food Products, Kazakh Academy of Nutrition, Almaty A05D9M8, Kazakhstan.
- Neurosis and Alzheimer's Disease Treatment Center, Almaty A05E1P7, Kazakhstan.
- School of General Medicine, Asfendiyarov Kazakh National Medical University, Almaty A05H2A6, Kazakhstan.
ORCID-Profile: Argul Issilbayeva, Samat Kozhakhmetov, Almagul Kushugulova, Sholpan Askarova, Dilyar Tuigunov, Zhibek Zholdassova, Yerzhan Omarov
Förderung
- Ministry of Science and Higher Education of the Republic of Kazakhstan
- Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Issilbayeva, A., Kozhakhmetov, S., Kushugulova, A., Askarova, S., Kaiyrlykyzy, A., Tuigunov, D., Dolmatova, O., Zholdassova, Z., Omarov, Y., & Nurgozhin, T. (2026). Gut Microbiome Alterations in Alzheimer’s Disease: A Shotgun Metagenomic Case–Control Study. International Journal of Molecular Sciences, 27(21), 9543. https://doi.org/10.3390/ijms27219543
Vancouver
Issilbayeva A, Kozhakhmetov S, Kushugulova A, Askarova S, Kaiyrlykyzy A, Tuigunov D, et al. Gut Microbiome Alterations in Alzheimer’s Disease: A Shotgun Metagenomic Case–Control Study. International Journal of Molecular Sciences. 2026;27(21):9543. doi:10.3390/ijms27219543
BibTeX
@article{Issilbayeva2026,
author = {Issilbayeva, Argul and Kozhakhmetov, Samat and Kushugulova, Almagul and Askarova, Sholpan and Kaiyrlykyzy, Aiym and Tuigunov, Dilyar and Dolmatova, Oksana and Zholdassova, Zhibek and Omarov, Yerzhan and Nurgozhin, Talgat},
title = {Gut Microbiome Alterations in Alzheimer’s Disease: A Shotgun Metagenomic Case–Control Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9543},
doi = {10.3390/ijms27219543}
}
EUVIMED